including ovarian cancer cells, which often present significant treatment challenges and can develop resistance to cisplatin.

This included ovarian cancer cells, which are known to develop resistance to cisplatin treatment in many cases. "Drug resistance is a significant challenge in cancer therapy," said Plebanski ...

A new study from Cedars-Sinai Cancer reveals a potential way to overcome tumor resistance to a common chemotherapy drug ...

etoposide and cisplatin. This combination is very good at preventing germ cell cancers from coming back. Rarely, you might have radiotherapy to try and shrink the cancer and reduce the symptoms of ...

A prospective, longitudinal study sought to determine the effects of nutrition status, daily habits, and sleep pattern on length of stay in patients with ovarian cancer undergoing chemotherapy.

The 2023 chemotherapy shortage led to a 60% drop in cisplatin use for head and neck cancer, with costly substitutes ...

Epithelial ovarian cancer is the fourth biggest cause of cancer-related death in women. Over recent decades, improvements have been made in treatment outcome in terms of response rate and survival.

An analysis of national data found that short-term mortality was not impacted for patients with advanced cancers during the shortage of the generic platinum chemotherapy drugs cisplatin and ...

Shortages of platinum-based chemotherapy drugs raise concerns as they may lead to increased cancer mortality due to delayed ...

Ovarian cancer is when abnormal cells in the ovary, fallopian tube or peritoneum begin to grow and divide in an uncontrolled way. They eventually form a growth (tumour). If not caught early, cancer ...